The PRESERVE Trial: Prevention of Serious Adverse Events following angiography [ 2011 - 2016 ]

Research Grant

Researchers: Prof Alan Cass (Principal investigator) ,  A/Pr Martin Gallagher ,  Prof David Brieger ,  Prof Derek Chew ,  Prof Graham Hillis
View all 6 related researchers

Brief description More than 75,000 coronary angiograms are performed each year in Australia. The dye used in angiograms can cause acute kidney injury (AKI); with diabetes, pre-existing kidney disease and heart failure putting people at high risk. Consequences include irreversible kidney failure requiring dialysis and risk of death. Little evidence support currently used prevention strategies. The PRESERVE Trial will recruit 5,200 people to provide definitive evidence to guide prevention of AKI.

Funding Amount $AUD 2,424,334.53

Funding Scheme Project Grants

Notes Standard Project Grant